Search
Blog Post
Cancer Innovations: Prioritizing quality of life while treating cancer
… the Cell Stress and Biophysical Therapy Program, and Emese Zsiros, MD, PhD, FACOG , Director of Research in the … more — and better quality — time with their loved ones Dr. Zsiros has spent the past several years researching the use … was 8-15%. The combination has a synergistic effect,” Dr. Zsiros says. “The typical treatments for ovarian cancer …
Blog Post
Why women with ovarian cancer should consider clinical trials
The Shashi Lele, MD, Familial Ovarian Cancer Registry
News
Roswell Park Team Assesses Addition of Complement Inhibitor Drug to Immunotherapy for Ovarian Cancer
News
Roswell Park Researchers Uncover Clues to Immunotherapy Response in Patients with Recurrent Ovarian Cancer
Blog Post
Cancer Innovations: New initiative reduced prescribed opioids by 45%
Cancer Types
Recurrent Ovarian Cancer
Clinical Trial
A PHASE 1, OPEN-LABEL, DOSE ESCALATION AND DOSE EXPANSION STUDY FOR LNCB74, A B7-H4 TARGETED ANTIBODY DRUG CONJUGATE, AS MONOTHERAPY IN PARTICIPANTS WITH ADVANCED SOLID TUMORS
Clinical Trial